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SUMMArY – The aim of the study was to assess the use of echocardiographic measurements 
in newborns of diabetic mothers. Maternal diabetes is associated with an increased risk of morbidity 
and mortality in pregnancy and in perinatal period. Thirty-five newborns of diabetic mothers (pre-
gestational or gestational diabetes; case group) and thirty-five controls (control group), born between 
January 2009 and december 2012 in Cluj-napoca (north-west of romania), were included in this 
study. A logiq e ultrasound with an 8 Mhz transducer was used to measure echocardiographic 
parameters. The interventricular septal thickness in case group was higher as compared with control 
group (at end systole = 6.61±1.64 mm vs. 5.75±0.95 mm, p=0.0371; at end diastole = 4.61±1.59 mm 
vs. 3.42±0.70 mm, p=0.0001). A risk ratio of 2.333 (0.656, 8.298) was obtained for septal hyper-
trophy. A higher proportion of septal hypertrophy was identified in the newborns of mothers with 
gestational diabetes compared to the newborns of pregestational diabetes mothers (p=0.0058). The 
mean birth weight was significantly higher in newborns of diabetic mothers (3695.57±738.63) as 
compared with controls (3276.14±496.51; p=0.0071). infants born to mothers with diabetes proved 
to be at a high risk of septal hypertrophy.
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Introduction
diabetes mellitus is a group of metabolic diseases 
characterized by hyperglycemia that is the result of 
secretion deficiency and/or dearth of activity1. diabe-
tes is associated with an increased risk of morbidity 
and mortality both in pregnancy and in perinatal pe-
riod2. Fetal and neonatal complications depend on the 
time of gestational diabetes onset3. in the first quar-
ter, diabetes can cause early slowing of growth and 
an early increased risk of congenital anomalies. in the 
second quarter, macrosomia, selective organomegaly, 
and slowing of the central nervous system develop-
ment occur. in the third quarter, chronic hypoxemia 
and death in utero are caused by diabetes. Perinatal 
mortality of infants born to mothers with diabetes 
has declined over the past 30 years but remains high 
when compared with the general population. two 
multicenter trials have reported mortality of 4.4% 
versus 0.7% (France4), and 4.6% versus 1.25% (new 
Zealand5). The risk of fetal death is 4-5 times higher 
in pregnancies with pre-existing insulin-dependent 
diabetes mellitus and it becomes even higher when as-
sociated with acidosis, hypertension or preeclampsia4. 
Fetal hypoxia occurs in infants of diabetic mothers as 
a result of the increased demand of oxygen because of 
hyperinsulinism and decrease in the capacity of the 
placenta to compensate for this increased demand. 
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The incidence is 25% of newborns of mothers with 
diabetes mellitus6. The risk of respiratory distress in 
this category of newborns is 3-5 times higher than 
in the general population (25%-38%) and it is due to 
qualitative surfactant deficiency7. Congenital mal-
formations are 2 to 4 times more common in cases 
with pregestational diabetes than in normal pregnan-
cy. The incidence is variable, i.e. 4.1% if only severe 
malformations are taken into account, or 7.9% as also 
reported in the respective literature6,8. There are mul-
ticenter studies which have identified an incidence of 
malformations of 8.3% for cases in which glycosylated 
hemoglobin was higher than 8% in the first trimester 
and 2.5% for cases in which glycosylated hemoglobin 
was lower than 8%9,10. isolated septal hypertrophy is 
present in 35%-40% of the infants born to diabetic 
mothers, but only 10% show signs of heart failure11. 
The cause is maternal hyperinsulinemia and it occurs 
in late pregnancy, week 34-40, when the process of 
glycogen storage in the septum is present. Myocardial 
hypertrophy, however, may occur despite adequate 
control of the maternal blood glucose. it is mostly as-
ymptomatic, but severe forms with obstruction in the 
left ventricular ejection may also appear, leading to 
heart failure. in most cases, complete regression can 
be noticed before the age of 6 months. in addition, the 
risk of developing pulmonary hypertension is higher 
in infants of mothers with diabetes mellitus12.
The progress made in recent years in monitor-
ing the newborns of diabetic mothers has reduced 
perinatal mortality, but significant morbidity is still 
recorded6,12. Considering this trend, the aim of our 
study was to evaluate the newborns of diabetic moth-
ers by echocardiography to early identify any heart 
problems.
Subjects and Methods
This cross-sectional study included infants born at 
the 1st Clinical hospital of Obstetrics and gynecol-
ogy, a teaching hospital in the north-west of roma-
nia and a tertiary-Care Perinatal Center in romania. 
The study was conducted between January 2009 and 
december 2012 and included a total of 70 subjects. 
two groups of newborns were investigated: a group 
of newborns of diabetic mothers (diabetes mellitus 
type 1 or 2 diagnosed before pregnancy or gestational 
diabetes as case group) and a group of newborns of 
non-diabetic mothers (control group). For each sub-
ject meeting the inclusion criteria in the case group, 
a matched subject in terms of gender and gestational 
age was identified and included in the control group. 
no macrosomic newborns of non-diabetic mothers 
were included in the study. An informed consent for 
including newborns in the study was obtained from 
all parents.
The following maternal variables were collected: 
type of diabetes (pregestational or gestational), when 
diabetes was diagnosed (maternal age for pregesta-
tional diabetes and gestational age expressed in weeks 
for gestational diabetes), the highest maternal blood 
glucose level (mg/dl) and glycosylated hemoglobin 
(%) during pregnancy.
The following data were collected for each new-
born included in the study:
•	 demographic characteristics: gender (female/
male), weight (g), head circumference (cm), and 
type of delivery (vaginal/cesarean). Ponderal in-
dex (Pi) was calculated for each subject using the 
following formula: Pi = 100·weight (kg)/height 
(cm3)13. Furthermore, the brain:body weight ratio 
(bbr) as an indicator of head-to-body proportion-
ality was calculated by applying the following for-
mula: bbr = 100· [0.037·cranial-perimeter)2.57]/
birth-weight (g)14. The weight at discharge was 
also recorded.
•	 Clinical characteristics: Apgar score at 1 and 5 
minutes after birth, obstetric trauma, hyperbili-
rubinemia, and jaundice were recorded. Moreover, 
the application of resuscitation procedures (di-
chotomous variable yes/no), as well as the length 
of hospital stay were also recorded.
•	 Para-clinical characteristics: glycemia and AS-
trUP parameters were investigated for infants of 
diabetic mothers using the Critical Care Express, 
nova biomedical. Post-birth glycemia of new-
borns of diabetic mothers was evaluated by the 
blood sugar level (mg/dl) at 1 hour after birth (a 
value less than 40 mg/dl was considered as hypo-
glycemia). The glucose required for correcting the 
glycemia to normal values (40-120 mg/dl) was 
calculated for each newborn with hypoglycemia.
•	 Echocardiographic assessment by M-mode in-
cluded right ventricular anterior wall thickness 
(rVAwt, expressed in mm), right ventricular end 
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diastolic dimension (rVEdd, expressed in mm), 
right ventricular end systolic dimension (rVESd, 
expressed in mm), thickness of interventricu-
lar septum at end systole (iVSs, mm), thickness 
of interventricular septum at end diastole (iVSd, 
mm), left ventricular end diastolic dimension 
(lVEdd, mm), left ventricular end systolic di-
mension (lVESd, mm), left ventricular posterior 
wall thickness (lVPwt, mm), and left ventricu-
lar fractional shortening (FS, %).
Echocardiographic measurements of the cardiac 
chamber section parasternal long axis were made in 
M-mode in all study subjects. Echocardiography di-
mensions were reported as weight at birth in the in-
fants weighing between 2000 and 4000 grams because 
the corporeal surface changes are minimal15. Over the 
weight of 4000 grams, the cardiac chamber dimen-
sions were assessed in relation to the calculated corpo-
real surface by the dubois and dubois formula16.
Echocardiography was performed with a logiq e 
general Electric ultrasound, 8 Mhz transducer cor-
responding to the newborn examination and cardiac 
examination, while the measurements were performed 
in M-mode, parasternal long axis from the left ven-
tricle as determined by standard echocardiography. 
The results were related and compared with the corre-
sponding ones in normal infants in Central Europe15. 
The shortening fraction was assessed representing the 
left ventricular end diastolic diameter minus left ven-
tricular systolic diameter × 100/left ventricular end 
diastolic diameter. The same physician in the same 
conditions performed echocardiography examination 
in all subjects included in the study.
The local Ethics Committees approved the study, 
and the study was conducted in accordance with the 
helsinki declaration.
Statistical analysis
Qualitative variables were summarized as abso-
lute and relative frequencies; relative frequencies were 
accompanied by 95% confidence intervals calculated 
with an optimized formula similar to the one present-
ed by Jäntschi and bolboacă17. The lower and upper 
limits of the 95% confidence intervals are provided 
along the manuscript in square brackets. Comparison 
between two proportions was conducted with the Z 
test for proportions at a significance level of 5%.
Quantitative variables were summarized as mean 
± standard deviation (Sd) when data proved normally 
distributed; otherwise, median and interquartile range 
was provided (interquartile range was provided as 
iQ=(Q1-Q3), where Q1=1st quartile, Q3=3rd quartile). 
The means for normally distributed variables were 
compared using Student’s t-test for independent sam-
ples. Quantitative variables not normally distributed 
were compared using Mann-whitney test.
Statistical analysis was conducted using the Statis-
tica (v.8, StatSoft inc., USA) software at a significance 
level of 5%.
Results
Seventy subjects were investigated, with identical 
distribution of gender and gestational age according 
to the method used for identification of subjects. in 
each group, we included 20 females (57.14% [40.08, 
74.20]) and 15 males (42.86% [25.80, 59.92]) with no 
significant gender difference (Z=-1.373, p=0.0943). 
The distribution of subjects according to gestational 
age (weeks) was identical for both groups and it was as 
follows: ≤36 weeks, 6 subjects (17.14% [5.80, 34.20]); 
37-38 weeks, 13 subjects (37.14% [20.08, 54.20]); 39-
40 weeks, 15 subjects (42.86% [25.80, 59.92]); and 41 
weeks, 1 subject (2.86% [0.08, 14.20]).
The mean of glycemia was significantly higher 
in mothers with gestational diabetes (148.91±59.03, 
min = 100, max = 330; t-stat = 2.49, p=0.0183) com-
pared to that in mothers with pregestational diabe-
tes (109.73±31.34, min = 90, max = 200). in the case 
group, 9 of 35 mothers also presented hypertension 
(25.71%, [11.51, 42.78]). glycosylated hemoglobin 
(normal values from 4% to 5.9%) was above the nor-
mal limits in 9 cases (25.71%, [11.51, 42.78]).
in the case group, 11 infants (31.43% [17.22, 
48.49]) were born to mothers with pregestational 
diabetes (mean age at diabetes diagnosis 12.91±6.66 
years) and 24 infants (68.57% [51.51, 82.78]) were 
born to mothers with gestational diabetes mellitus 
(28.59±7.42 gestational age; n=22; 4 cases treated with 
insulin) (Z statistics = 4.733, p<0.0001).
demographic characteristics of the subjects in-
cluded in the study are presented in table 1 and clini-
cal and para-clinical characteristics in table 2.
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The mean birth weight in newborns of diabetic 
mothers (3695.57±738.63) proved to be significantly 
higher compared to the mean birth weight in new-
borns of nondiabetic mothers (3276.14±496.51) 
(Student’s t-test = 2.7881, p=0.0071). The same dif-
ference was observed when the weight at discharge 
(day when the baby left the hospital) was compared 
between the groups (case: 3490.57±623.88; control: 
3064.00±448.58; t-test = 3.28, p=0.0017). Com-
parison of head circumference yielded no signifi-
cant between-group difference (34.80±1.94 for case 
group, 34.43±1.20 for control group, t-test = 0.9653, 
p=0.3384). Pi proved significantly higher in case 
Table 1. Demographic characteristics of study subjects according to groups
Variable Case group Control group Statistics
type of delivery 
Vaginal
Cesarean section
15 (42.86 [25.80, 59.92])
20 (57.14 [40.08, 74.20])
16 (45.71 [28.65, 62.78])










1 (2.86 [0.08, 14.20])
1 (2.86 [0.08, 14.20])
2 (5.71 [0.08, 19.92])
9 (25.71 [11.51, 42.78])
8 (22.86 [11.51, 39.92])
13 (37.14 [20.08, 54.20])
1 (2.86 [0.08, 14.20])
0 (0.00 [0.00, 8.49])
2 (5.71 [0.08, 19.92])
8 (22.86 [11.51, 39.92])
14 (40.00 [22.93, 57.06])
9 (25.71 [11.51, 42.78])
2 (5.71 [0.08, 19.92])













1 (2.86 [0.08, 14.20])
13 (37.14 [20.08, 54.20])
19 (54.29 [37.22, 71.35])
2 (5.71 [0.08, 19.92])
0 (0.00 [0.00, 8.49])
16 (45.71 [28.65, 62.78])
19 (54.29 [37.22, 71.35])












2 (5.71 [0.08, 19.92])
11 (31.43 [17.22, 48.49])
7 (20.00 [8.65, 37.06])
7 (20.00 [8.65, 37.06])
6 (17.14 [5.80, 34.20])
2 (5.71 [0.08, 19.92])
7 (20.00 [8.65, 37.06])
11 (31.43 [17.22, 48.49])
11 (31.43 [17.22, 48.49])
6 (17.14 [5.80, 34.20])
0 0 (0.00 [0.00, 8.49])














3 (8.57 [2.94, 22.78])
9 (25.71 [11.51, 42.78])
12 (34.29 [20.08, 51.35])
9 (25.71 [11.51, 42.78])
1 (2.86 [0.08, 14.20])
1 (2.86 [0.08, 14.20])
0 (0.00 [0.00, 8.49])
3 (8.57 [2.94, 22.78])
12 (34.29 [20.08, 51.35])
10 (28.57 [14.37, 45.63])
10 (28.57 [14.37, 45.63])







data are presented as n (%, [95%Ci]); Z test for comparison of two proportions; ns=not statistically significant; *p<0.05; **p<0.01; 
***p<0.001; ****p<0.0001 
subjects (2.29±0.32) compared to control subjects 
(2.08±0.22; t-test = 3.12, p=0.0027).
ten subjects from the case group required resusci-
tation procedures (25.71% [14.37; 45.63]). 
The following values (expressed as mean ± Sd) 
were obtained for AStrUP parameters (n=27): 
ph=7.31±0.08; pCO2=39.50±9.20; pO2=43.68±7.83; and 
bE (base excess)=-6.71±2.64. no significant differences 
were observed in AStrUP parameters when infants of 
pregestational diabetic mothers were compared with in-
fants of gestational diabetic mothers (p≥0.2267).
in the case group, global evaluation recorded two 
babies with hydronephrosis (5.71% [0.08, 19.92]), two 
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Table 2. Clinical and para-clinical characteristics of study subjects according to groups







2 (5.71 [0.08, 19.92])
8 (22.86 [11.51, 39.92])
3 (8.57 [2.94, 22.78])
12 (34.29 [20.08, 51.35])
10 (38.57 [14.37, 45.63])
0 (0.00 [0.00, 8.49])
0 (0.00 [0.00, 8.49])
8.57 [2.94, 22.78])
21 (60.00 [42.94, 77.06])











1 (2.86 [0.08, 14.20])
7 (20.00 [8.65, 37.06])
14 (40.00 [22.93, 57.06])
13 (37.14 [20.08, 54.20])
0 (0.00 [0.00, 8.49])
0 (0.00 [0.00, 8.49])
4 (11.43 [2.94, 25.63])










21 (60.00 [42.94, 77.06])
9 (25.71 [11.51, 42.78])
17 (48.57 [31.51, 65.63])
16 (45.71 [28.65, 62.78])
20 (57.14 [40.08, 74.20])
5 (14.29 [5.80, 31.35])
6 (17.14 [5.80, 34.20])





data are presented as n (%, [95%Ci]); Z test for comparison of two proportions; nsnot statistically significant; *p<0.05; **p<0.01; 
***p<0.001; ****p<0.0001
Table 3. Echocardiographic measurements
Variable
infants of diabetic mothers infants of nondiabetic mothers
Statistics 
Mean ± Sd Median (iQ) Mean ± Sd Median (iQ)
rVAwta (mm) 4.72±1.10 4.80 (3.90-5.50) 4.54±1.11 4.70 (3.50-5.30) 0.6804 ns 
rVESdb (mm) 9.46±3.18 9.30 (8.00-12.30) 9.85±2.69 10.30 (7.60-12.20) -0.1116 ns 
rVEdda (mm) 6.25±2.03 6.10 (5.50-7.60) 5.44±1.48 5.50 (4.20-6.50) 1.9125 ns
iVSsb (mm) 6.61±1.64 6.10 (5.50-7.70) 5.75±0.95 5.70 (5.30-6.40) 2.0791 *
iVSdb (mm) 4.61±1.59 4.50 (3.50-5.40) 3.42±0.70 3.40 (3.00-3.90) 3.7000 ***
lVEddb (mm) 15.81±2.22 15.40 (14.10-18.00) 15.71±2.40 16.40 (14.50-17.50) 0.1757 ns
lVESdb (mm) 11.43±2.64 11.90 (9.00-13.40) 10.97±2.56 11.30 (8.70-13.20) 0.5697 ns
lVPwtb (mm) 4.47±0.94 4.10 (3.90-5.00) 4.16±1.19 3.90 (3.30-4.80) 1.6856 ns
FSb (%) 28.21±13.06 24.14 (18.71-38.94) 30.37±11.31 25.81 (22.67-36.59) -1.4976 ns
iQ = interquartile range (Q1-Q3) where Q1 = first quartile; Q3 = third quartile; aStudent’s t-test; bMann-whitney test;
rVAwt = right ventricular anterior wall thickness; rVEdd = right ventricular end diastolic dimension; rVESd = right ventricular end 
systolic dimension; iVSs = thickness of interventricular septum at end systole; iVSd = thickness of interventricular septum at end diastole; 
lVEdd = left ventricular end diastolic dimension; lVESd = left ventricular end systolic dimension; lVPwt = left ventricular posterior wall 
thickness; FS = left ventricular fractional shortening; nsnot statistically significant; *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001
newborns with interatrial septal defect (5.71% [0.08, 
19.92]), one with persistent ductus arteriosus (2.86% 
[0.08, 14.20]) and one with cardiac hemangioma 
(2.86% [0.08, 14.20]).
in ten infants of diabetic mothers (28.57% [14.37, 
45.63], 3 infants of pregestational diabetic moth-
ers and 7 infants of gestational diabetic mothers, 
Z=2.7603, p=0.0058) septal hypertrophy was present 
compared to one infant of nondiabetic mother (2.86% 
[0.08, 14.20]). Thus, this percentage was statistical-
ly higher in the case group compared with controls 
(Z=3.1588, p=0.0016). One of the newborns (10% 
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[1.00, 39.00]) with septal hypertrophy, born to moth-
er with gestational diabetes, presented signs of heart 
failure (such as severe respiratory distress with pul-
monary hypertension) and needed respiratory support 
such as synchrony ventilation (SiMV) for 4 days; low 
cardiac output manifested hypotension and required 
treatment with propranolol. Considering the presence 
of diabetes during pregnancy as a risk factor for septal 
hypertrophy, a risk ratio of 2.333 [0.656, 8.298] was 
obtained.
Echocardiography measurements regarding ma-
ternal diabetes status are presented in table 3.
no significant echocardiographic measurement 
differences were identified in the newborns of diabetic 
mothers when comparing newborns of pregestational 
diabetes mothers and newborns of gestational diabe-
tes mothers (p≥0.3487).
hospital stay was significantly longer (Mann-
whitney test=-2.891; p=0.004) for the newborns of 
diabetic mothers (median (iQ )=7 days (4.5-8)) com-
pared to newborns of nondiabetic mothers (median 
(iQ )=5 days (3-5)).
Discussion
The investigated newborns of diabetic and nondia-
betic mothers were successfully evaluated by echocar-
diographic measurements. in our case group, 31.43% 
of mothers had pregestational diabetes and 68.57% of 
mothers had gestational diabetes, the difference being 
statistically significant (p<0.01). The mean gestation-
al age of the mothers with gestational diabetes was 
28.59±7.42 weeks of gestation; in one of 24 cases, in-
sulin treatment was applied. Screening for gestational 
diabetes usually is performed around 24-28 weeks of 
pregnancy18. The usual treatment is putting pregnant 
women on a diet, but in 31% insulin is needed as well19. 
it is well-known that the consequences of diabetes 
are different depending on whether it is of preges-
tational or gestational type. Pregestational diabetes 
occurs in 0.1%-0.3% of all pregnancies in the US20. 
On the other hand, gestational diabetes is more fre-
quent compared to pregestational diabetes and could 
be seen in almost 90% of pregnancies in the Ameri-
can population21,22. Thus, the higher frequency of ges-
tational diabetes obtained in our study is in keeping 
with the results published in the literature. As other 
authors have shown6, the blood sugar level of moth-
ers with gestational diabetes was significantly higher 
compared to the values of pregestational diabetes. in 
almost 26% of cases, the mothers with diabetes also 
had associated hypertension, while almost 26% of the 
women presented higher values of glycosylated hemo-
globin compared to the expected normal values. These 
results are comparable with the results reported from 
other studies6,20,23,24. note that no changes in the left 
ventricular systolic function were identified in women 
with diabetes25.
in our sample, glycosylated hemoglobin (normal 
values from 4% to 5.9%) was above the normal lim-
its in 9 (25.71%) cases. Mothers with values of less 
than 7% have no greater risk of having an infant with 
congenital anomalies than mothers without diabe-
tes. For mothers with values between 7% and 8.5%, 
the risk is 5%; the risk rises to 22% in mothers with 
hemoglobin A1c values of more than 10%12,26. in our 
study, there were no differences according to type of 
delivery or head circumference between cases and 
controls (p>0.05) (table 1). The mean birth weight of 
the newborns of diabetic mothers (3695.57±738.63) 
proved significantly higher compared to the mean 
birth weight of the newborns of nondiabetic mothers 
(3276.14±496.51) (Student’s t-test=2.7881, p=0.0071) 
and this difference could be attributed to the number 
of newborns with birth weight higher than or equal to 
4000 g (p<0.01) (table 1). The presence of macroso-
mia is one of the adverse outcomes of diabetes in preg-
nancy, besides congenital anomalies, preterm birth, 
neonatal hypoglycemia, and neonatal death4,7,27,28. 
galić and grgurić proved that newborns of employed 
parents had higher birth weight compared to those 
of unemployed parents29. depending on the mater-
nal metabolic and proinflammatory derangements, 
macrosomia is explained by excessive availability 
of nutrients and an increase in fetal insulin release, 
a phenotype related to the programming of glucose 
intolerance30. because of the higher birth weight, Pi 
was also significantly higher in the newborns of dia-
betic mothers compared to newborns of nondiabetic 
mothers (p<0.01). Furthermore, bbr equal to 11.9 
was identified in a significantly lower number of new-
borns of diabetic mothers compared to the newborns 
of nondiabetic mothers. This result could be explained 
by the presence of macrosomia in the newborns of di-
abetic mothers. 
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besides macrosomia, which was the most frequent 
morbidity in our sample, we also identified a signifi-
cantly higher number of newborns with hypoglycemia 
and birth injuries (p<0.01 both) in the newborns of 
diabetic mothers compared to the newborns of non-
diabetic mothers (table 2). The prevalence of hypo-
glycemia in our case group was 45.71%. A study from 
india on 574 newborns of gestational diabetes moth-
ers showed a 9.3% incidence of hypoglycemia and 
2.5% incidence of birth injuries31. The percentage of 
newborns with Apgar score 8 or 9 at 5 minutes proved 
significantly higher compared to controls, while the 
percentage of newborns of diabetic mothers with Ap-
gar score 10 at 5 minutes proved significantly lower 
compared to the newborns of nondiabetic mothers 
(see table 2). These results could be explained by both 
obstetric trauma (see table 2) and the need of resusci-
tation (28.57% of newborns of diabetic mothers com-
pared to no newborn of nondiabetic mother), which 
were more frequent in the newborns of diabetic moth-
ers compared to the newborns of nondiabetic moth-
ers. Other comorbidities observed in our newborns of 
diabetic mothers were as follows: two newborns with 
hydronephrosis, two newborns with interatrial septal 
defect, one newborn with persistent ductus arteriosus, 
and one newborn with cardiac hemangioma. Several 
epidemiological studies have demonstrated strong as-
sociation between maternal glycemic level control at 
the time of conception and during early gestation and 
the incidence of congenital anomalies26,32. More than 
50% of these anomalies affect the central nervous sys-
tem or cardiovascular system12,31.
The most common renal anomalies are hydro-
nephrosis, renal agenesis, and cystic kidneys26. in our 
study, there were just two newborns with hydroneph-
rosis (5.7%).
Echocardiographic measurements performed on the 
case group showed similar results in both  newborns 
of diabetic mothers and those of nondiabetic mothers 
(see table 3), with significant differences just in case 
of interventricular septum thickness at end systole 
and interventricular septum thickness at end diastole 
(p<0.05), the differences being greater in systole. be-
sides differences in echocardiographic measurements, 
a significantly higher percentage of newborns of dia-
betic mothers had septal hypertrophy as compared with 
newborns of nondiabetic mothers (p<0.01). 
isolated septal hypertrophy is present in 35%-
40% of infants born to mothers with diabetes, where 
echocardiographic screening is performed11. The in-
cidence of symptomatic forms is 10%-12%9,27. in 
our study, the incidence of septal hypertrophy was 
28.57%, which is less than the percentage mentioned 
in the literature9,27. This can be explained by the small 
number of subjects in the study group or by differ-
ences between the groups.
Seven of ten infants with septal hypertrophy iden-
tified in our study were born from pregnancies with 
gestational diabetes. This result may indicate the need 
of early diagnosis and correct treatment of diabetes, 
with appropriate monitoring. in our study, the mean 
age at the diagnosis was 28.59±7.42 weeks of gesta-
tion and the mean blood glucose during pregnancy 
was higher in patients with gestational diabetes. Only 
10% of the newborns with hypertrophic cardiomyo-
pathy showed signs of heart failure8,26. Only one of 
ten (10%) infants with septal hypertrophy in the case 
group showed signs of heart failure, while the others 
were asymptomatic. These results are similar to those 
reported in the literature8,26.
given the complications in infants born to moth-
ers with diabetes, the length of hospital stay was lon-
ger (7 days) compared to that in controls (5 days).
The association of diabetes in pregnancy and neo-
natal septal hypertrophy was investigated and a val-
ue of 2 was obtained. This value showed that in our 
sample, a newborn of diabetic mother had a twofold 
higher risk to have septal hypertrophy than a new-
born of nondiabetic mother. Since the value of 1 is 
included in the 95% confidence interval of risk ratio, 
the result obtained was true for our sample but could 
not be generalized. 
Echocardiographic measurements in the newborns 
of diabetic mothers were not significantly different 
from those of the newborns of nondiabetic mothers, 
with the exception of the interventricular septum 
thickness. in our study, the incidence of septal hy-
pertrophy was 28.57%. This comorbidity proved to be 
more frequent in the newborns of gestational diabetes 
mothers compared to the newborns of pregestational 
diabetes mothers. This result could be explained by 
the presence of better glucose control in the moth-
ers with pregestational diabetes as compared to those 
with gestational diabetes. The association of maternal 
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diabetes and cardiomyopathy, specifically septal wall 
hypertrophy, is a well-known phenomenon, and it has 
been previously described33,34. 
Our study had some limitations, the most impor-
tant being generalizability, which was limited by both 
the population sample and sample size. So, the results 
obtained are certainly true for the investigated sam-
ple, but are they also true for the romanian popula-
tion? Furthermore, the small sample size in this study 
did not ensure a reasonable power for our study (post-
hoc power is ~50%). in this study, financial resources 
limited the sample size and thus this study could be 
seen as a pilot study able to generate further research 
hypothesis. Another limitation is related to study de-
sign; since our design was cross-sectional, the causal 
relationship could not be investigated.
nevertheless, according to our knowledge, this 
is the first study conducted on romanian infants of 
diabetic mothers that evaluated the presence of sep-
tal wall hypertrophy and echocardiographic changes 
at birth. As a result, this study suggests that even if 
symptoms appear only in 10% of cases, echocardio-
graphic morphological changes are common in in-
fants born to diabetic mothers.
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Sažetak
KliniČKi i EhOKArdiOgrAFSKi nAlAZi U nOVOrOĐEnČAdi diJAbEtiČnih MAJKi 
M. G. Hăşmăşanu, S. D. Bolboacă, M. Matyas i G. C. Zaharie
Cilj je bio procijeniti primjenu ehokardiografskih mjerenja u novorođenčadi dijabetičnih majki. Majčin dijabetes udru-
žen je s povećanim rizikom pobola i smrtnosti u trudnoći i tijekom perinatalnog razdoblja. U ispitivanje je bilo uključeno 
35 novorođenčadi dijabetičnih majki (predgestacijski ili gestacijski dijabetes; ispitna skupina) i 35 kontrolne novorođen-
čadi (kontrolna skupina) rođene između siječnja 2009. i prosinca 2012. godine u području Cluj-napoca (sjeverozapadna 
rumunjska). Ehokardiografski parametri mjereni su pomoću ultrazvučnog uređaja logiq e s pretvornikom od 8 Mhz. 
debljina interventrikulskog septuma bila je viša u ispitnoj skupini u usporedbi s kontrolnom skupinom (na kraju sistole 
= 6,61±1,64 mm prema 5,75±0,95 mm, p=0,0371; na kraju dijastole = 4,61±1,59 mm prema 3,42±0,70 mm, p=0,0001). 
Omjer rizika za septalnu hipertrofiju bio je 2,333 (0,656; 8,298). U novorođenčadi majki s gestacijskim dijabetesom za-
bilježen je veći udio hipertrofije septuma u usporedbi s novorođenčadi majki s predgestacijskim dijabetesom (p=0,0058). 
Srednja porođajna težina novorođenčadi dijabetičnih majki (3695,57±738,63) bila je značajno viša u usporedbi s kontrol-
nom skupinom (3276,14±496,51; p=0,0071). Kod novorođenčadi majki s dijabetesom utvrđen je visok rizik od hipertrofije 
septuma.
Ključne riječi: Novorođenče; Trudnoća – komplikacije; Dijabetes melitus; Ehokardiografija; Hipertrofija; Srčana pregrada – 
patologija
